Obesity and cancer risk: Emerging biological mechanisms and perspectives - PubMed (original) (raw)
Review
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos I Avgerinos et al. Metabolism. 2019 Mar.
Abstract
Continuously rising trends in obesity-related malignancies render this disease spectrum a public health priority. Worldwide, the burden of cancer attributable to obesity, expressed as population attributable fraction, is 11.9% in men and 13.1% in women. There is convincing evidence that excess body weight is associated with an increased risk for cancer of at least 13 anatomic sites, including endometrial, esophageal, renal and pancreatic adenocarcinomas; hepatocellular carcinoma; gastric cardia cancer; meningioma; multiple myeloma; colorectal, postmenopausal breast, ovarian, gallbladder and thyroid cancers. We first synopsize current epidemiologic evidence; the obesity paradox in cancer risk and mortality; the role of weight gain and weight loss in the modulation of cancer risk; reliable somatometric indicators for obesity and cancer research; and gender differences in obesity related cancers. We critically summarize emerging biological mechanisms linking obesity to cancer encompassing insulin resistance and abnormalities of the IGF-I system and signaling; sex hormones biosynthesis and pathway; subclinical chronic low-grade inflammation and oxidative stress; alterations in adipokine pathophysiology; factors deriving from ectopic fat deposition; microenvironment and cellular perturbations including vascular perturbations, epithelial-mesenchymal transition, endoplasmic reticulum stress and migrating adipose progenitor cells; disruption of circadian rhythms; dietary nutrients; factors with potential significance such as the altered intestinal microbiome; and mechanic factors in obesity and cancer. Future perspectives regarding prevention, diagnosis and therapeutics are discussed. The aim of this review is to investigate how the interplay of these main potential mechanisms and risk factors, exerts their effects on target tissues provoking them to acquire a cancerous phenotype.
Keywords: Adipokine; Adiponectin; Biomarker; Cancer; Inflammation; Microbiome; Obesity; Resistin; Visfatin.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
- Gender Differences in Obesity-Related Cancers.
Argyrakopoulou G, Dalamaga M, Spyrou N, Kokkinos A. Argyrakopoulou G, et al. Curr Obes Rep. 2021 Jun;10(2):100-115. doi: 10.1007/s13679-021-00426-0. Epub 2021 Feb 1. Curr Obes Rep. 2021. PMID: 33523397 Review. - Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms.
Friedenreich CM, Ryder-Burbidge C, McNeil J. Friedenreich CM, et al. Mol Oncol. 2021 Mar;15(3):790-800. doi: 10.1002/1878-0261.12772. Epub 2020 Aug 18. Mol Oncol. 2021. PMID: 32741068 Free PMC article. Review. - Obesity and Risk of Cancer: An Introductory Overview.
Pischon T, Nimptsch K. Pischon T, et al. Recent Results Cancer Res. 2016;208:1-15. doi: 10.1007/978-3-319-42542-9_1. Recent Results Cancer Res. 2016. PMID: 27909899 Review. - Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
Tsilingiris D, Vallianou NG, Spyrou N, Kounatidis D, Christodoulatos GS, Karampela I, Dalamaga M. Tsilingiris D, et al. Curr Obes Rep. 2024 Mar;13(1):1-34. doi: 10.1007/s13679-023-00542-z. Epub 2023 Dec 30. Curr Obes Rep. 2024. PMID: 38159164 Free PMC article. Review. - Obesity and Cancer: Evidence, Impact, and Future Directions.
Colditz GA, Peterson LL. Colditz GA, et al. Clin Chem. 2018 Jan;64(1):154-162. doi: 10.1373/clinchem.2017.277376. Epub 2017 Oct 16. Clin Chem. 2018. PMID: 29038151 Review.
Cited by
- The Role of Body Mass Index (BMI) in Differentiated Thyroid Cancer: A Potential Prognostic Factor?
Mele C, De Marchi L, Marsan G, Zavattaro M, Mauri MG, Aluffi Valletti P, Aimaretti G, Marzullo P. Mele C, et al. Biomedicines. 2024 Aug 29;12(9):1962. doi: 10.3390/biomedicines12091962. Biomedicines. 2024. PMID: 39335476 Free PMC article. - Association of systemic immune-inflammation index with body mass index, waist circumference and prevalence of obesity in US adults.
Yang S, Zhang S, Deng J, Xie J, Zhang J, Jia E. Yang S, et al. Sci Rep. 2024 Sep 27;14(1):22086. doi: 10.1038/s41598-024-73659-3. Sci Rep. 2024. PMID: 39333666 Free PMC article. - The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies.
Lysaght J, Conroy MJ. Lysaght J, et al. Nat Rev Endocrinol. 2024 Sep 23. doi: 10.1038/s41574-024-01032-5. Online ahead of print. Nat Rev Endocrinol. 2024. PMID: 39313571 Review. - Repurposing Drugs for Cancer Prevention: Targeting Mechanisms Common to Chronic Diseases.
Choradia N, Szabo E. Choradia N, et al. Cancer J. 2024 Sep-Oct 01;30(5):345-351. doi: 10.1097/PPO.0000000000000746. Cancer J. 2024. PMID: 39312454 Review. - Sedentary and 21 gastrointestinal disorders: A Mendelian randomization study.
Lin Y, He J, Ding Z. Lin Y, et al. Medicine (Baltimore). 2024 Sep 20;103(38):e39813. doi: 10.1097/MD.0000000000039813. Medicine (Baltimore). 2024. PMID: 39312361 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases